Invacare — Baird Healthcare Conference 2021
12 slides from Invacare's conference presentation, Sep 14, 2021
Slide 1: Investor Presentation - Baird Healthcare Conference
I N VA C A R E C O R P O R AT I O N Investor Presentation (NYSE: IVC) Baird Healthcare Conference September 14, 2021
Slide 2: Forward Looking Statements
I N VA C A R E C O R P O R AT I O N Forward Looking Statements This presentation contains forward-looking statements within the meaning of the “Safe Harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are those that describe future outcomes or expec
Slide 3: Making Life's Experiences Possible
I N VA C A R E C O R P O R AT I O N Making Life’s Experiences Possible Who We Are What We Do Celebrating over 40 years of Making Life’s Experiences Possible Headquartered near Cleveland, OH Design, manufacture and distribute durable medical equipment for congenital, acquired and degenerative conditi
Slide 4: Reported Net Sales and Broad Product Line with High Clinical Value
Reported Net Sales * Broad Product Line with High Clinical Value I N VA C A R E C O R P O R AT I O N $450 $403 $858 $400 Million* Lifestyle (47%) $350 $324 Globally focused on home healthcare and post-acute care, including aids for daily living, walking aids, lifts, wheelchairs, $300 beds and surfac
Slide 5: Initiatives Accelerating Our Multi-Year Strategy to Return to Profitability
I N VA C A R E C O R P O R AT I O N Initiatives Accelerating Our Multi-Year Strategy to Return to Profitability Award winning clinical solutions and full product pipeline: ✓ Launched center-wheel, front-wheel and rear-wheel drive standing positioning system with clinical and social benefits of verti
Slide 6: Innovation Pipeline
Innovation Pipeline Rehab (Mobility and Seating) Supporting sales growth with frequent introduction of clinically innovative solutions Post Acute Care (Lifestyle) Respiratory I N VA C A R E C O R P O R AT I O N Jan Ampla bariatric manual chair May Mar Jul Aug SMOOV AVIVA® FX / Clematis Pro AVIVA One
Slide 7: Culture of Innovation & Process Improvements Paves Way for Growth
Culture of Innovation & Process Improvements Paves Way for Growth I N VA C A R E C O R P O R AT I O N Product introductions in all categories to drive incremental sales at higher margins Business Optimization ✓ Customer friendly e- commerce portal expected to launch in North America in 4Q21 ✓ Comple
Slide 8: Demonstrated Improvement in Financial Performance
I N VA C A R E C O R P O R AT I O N Demonstrated Improvement in Financial Performance % of Net Sales Operating Income (Loss) 29.5% 29.0% 28.8% 29.0% ($18.3) 2018 28.5% 28.2% 28.0% ($10.4) 2019 27.5% 28.0% 27.5% 27.8% 27.0% 2020 2020* $11.3 26.5% 2018 2019 2020 ($20.0) ($15.0) ($10.0) ($5.0) $0.0 $5.
Slide 9: Recent Concurrent Global Supply Chain and COVID-19 Related Disruptions
Recent Concurrent Global Supply Chain and COVID-19 Related Disruptions Temporarily Impacting Growth I N VA C A R E C O R P O R AT I O N Three key factors in mid- to late-August temporarily impacted revenue growth in 3Q21. Actions to limit the impact have been taken. Benefits will correct trajectory,
Slide 10: 2021 Financial Guidance
2021 Financial Guidance The company anticipates increased customer activity and demand for its products even as I N VA C A R E C O R P O R AT I O N Adjusted EBITDA the pandemic continues to present challenges related to labor, material and freight (in millions) availability. These challenges are mod
Slide 11: Business Improvement Highlights
I N VA C A R E C O R P O R AT I O N Business Improvement Highlights We are striving to regain market leadership We have a clear roadmap to further enhance and simplify our operations Key Takeaways We have a strong pipeline of innovative products coming to market Our financial performance is improvin
Slide 12: Thank You
I N VA C A R E C O R P O R AT I O N Thank You Invacare Corporation: Baird Healthcare Conference – Sep 14, 2021